Cryo-Cell International Statistics
Want to see CCEL full AI Analyst Report?
Cryo-Cell International (CCEL) Stock Statistics & Valuation Metrics
Total Valuation
Cryo-Cell International has a market cap or net worth of $36.69M. The enterprise value is $38.46M.
- Market Cap
- $36.69M
- Enterprise Value
- $38.46M
Share Statistics
Cryo-Cell International has 8,062,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,062,650
- Owned by Insiders
- 34.66%
- Owned by Institutions
- 6.35%
Financial Efficiency
Cryo-Cell International’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.79%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- -0.04
- Return on Invested Capital (ROIC)
- 10.79%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 426.57K
- Profits Per Employee
- -32.83K
- Employee Count
- 74
- Asset Turnover
- 0.51
- Inventory Turnover
- 18.04
Valuation Ratios
The current PE Ratio of Cryo-Cell International is -18.33. Cryo-Cell International’s PEG ratio is 0.05.
- PE Ratio
- -18.33
- PS Ratio
- 1.06
- PB Ratio
- -2.02
- Price to FCF
- 7.12
- Price to Operating Cash Flow
- 6.73
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.57M and earned -2.43M in profits. Earnings per share was -0.30.
- Revenue
- 31.57M
- Gross Profit
- 24.19M
- Operating Income
- 4.84M
- Pretax Income
- -2.34M
- Net Income
- -2.43M
- EBITDA
- 1.10M
- Earnings Per Share (EPS)
- -0.30
Cash Flow
In the last 12 months, operating cash flow was 4.92M and capital expenditures -268,871, giving a free cash flow of 4.65M billion.
- Operating Cash Flow
- 4.92M
- Free Cash Flow
- 4.65M
- Free Cash Flow per Share
- 0.58
Dividends & Yields
Cryo-Cell International pays an annual dividend of $0.15, resulting in a dividend yield of ―
- Dividend Per Share
- $0.15
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 14.04%
- Earnings Yield
- -8.51%
Stock Price Statistics
- Beta
- 0.13
- 52-Week Price Change
- 10.71%
- 50-Day Moving Average
- 4.47
- 200-Day Moving Average
- 3.77
- Relative Strength Index (RSI)
- 51.09
- Average Volume (3m)
- 13.69K
Important Dates
Cryo-Cell International upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 09, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- May 21, 2025
Financial Position
Cryo-Cell International as a current ratio of 0.59, with Debt / Equity ratio of -62.12%
- Current Ratio
- 0.59
- Quick Ratio
- 0.57
- Debt to Market Cap
- 0.33
- Net Debt to EBITDA
- 10.24
- Interest Coverage Ratio
- 2.34
Taxes
In the past 12 months, Cryo-Cell International has paid 92.23K in taxes.
- Income Tax
- 92.23K
- Effective Tax Rate
- -0.04
Enterprise Valuation
Cryo-Cell International EV to EBITDA ratio is 27.01, with an EV/FCF ratio of 6.94.
- EV to Sales
- 1.04
- EV to EBITDA
- 27.01
- EV to Free Cash Flow
- 6.94
- EV to Operating Cash Flow
- 6.56
Balance Sheet
Cryo-Cell International has $4.23M in cash and marketable securities with $577.20K in debt, giving a net cash position of $3.65M billion.
- Cash & Marketable Securities
- $4.23M
- Total Debt
- $577.20K
- Net Cash
- $3.65M
- Net Cash Per Share
- $0.45
- Tangible Book Value Per Share
- -$2.38
Margins
Gross margin is 77.95%, with operating margin of 0.61%, and net profit margin of -9.05%.
- Gross Margin
- 77.95%
- Operating Margin
- 0.61%
- Pretax Margin
- -6.13%
- Net Profit Margin
- -9.05%
- EBITDA Margin
- 3.84%
- EBIT Margin
- -0.49%
Analyst Forecast
The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -1.96%
- EPS Growth Forecast
- -314.41%
Scores
- Smart Score
- 5
- AI Score
- 52

